SOPHARMA AD: CONSOLIDATED FINANCIAL STATEMENTS FOR Q1 2016

opublikowano: 2016-05-30 14:16

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
SPH_Conso_Q1_2016.zip  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
<html>
<head>

</head>
<body><font face='Times New Roman'>
<p>

</p>
</font></body>
</html>
 <font face='Times New Roman'></font> <font face='Times New Roman'></font> UNI - EN REPORT No 50 / 2016 <html>
<head>

</head>
<body>
</body>
</html>
 <font face='Times New Roman'></font>
Date of issue: 2016-05-30
Short name of the issuer
SOPHARMA AD
Subject
CONSOLIDATED FINANCIAL STATEMENTS FOR Q1 2016
Official market - legal basis
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieї№ce i okresowe
Unofficial market - legal basis
Contents of the report:
CONSOLIDATED FINANCIAL STATEMENTS FOR Q1 2016

1. Financial Statements
2. Notes to the Financial Statements
3. Management report
4. Templates of the financial reports approved by the Bulgarian FSC
5. Declaration
Annexes
File Description
SPH Conso Q1 2016.zipSPH Conso Q1 2016.zip CONSOLIDATED FINANCIAL STATEMENTS FOR Q1 2016

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-05-30 Ognian Donev Executive director